Loading Page
Dr. Stuart Schiff, DO is a pediatrician in Cedarhurst, NY specializing in general pediatrics. Dr. Stuart Schiff, DO is affiliated with Optum East.
He has a state license in New York.
Licensed In: New York
Dr. Stuart Schiff, DO is associated with these hospitals and organizations:
Dr. Stuart Schiff, DO appears to accept the following insurance providers: Magnacare, Great West Healthcare, EmblemHealth Plan, Inc, Oscar, Fidelis, Multiplan, Affinity by Molina Healthcare, United Healthcare, Aetna, Tricare, Oxford, Consumer Health Network, Medicare, Healthfirst, Empire Blue Cross Blue Shield, Humana, Coventry, Cigna, Anthem Blue Cross Blue Shield, MVP Health Care, Connecticare, First Health Network, Private Healthcare Systems, Centivo, Northwell Direct Network, The New York State Health Insurance Program, CDPHP, Health Insurance Plan of Greater Network and Partners Health Plan.
According to our sources, Dr. Stuart Schiff, DO accepts the following insurance providers:
Dr. Stuart Schiff, DO has an exceptional overall rating with an average of 4.83 out of 5 stars based on 12 ratings. We collect ratings and reviews of Dr. Stuart Schiff, DO from all over the web to help you find the right in Cedarhurst, NY.
These charts describe general payments received by Dr. Stuart Schiff, DO. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$255
Menveo $30 |
$225 |
|||||
|
$173
EpiPen $173 |
||||||
|
$127
TRUMENBA $127 |
||||||
|
$90
Auvi-Q $90 |
||||||
|
$82
Spot Vision Screener $62 |
Microtymp $19 |
|||||
|
$274
PROAIR $50 |
Norditropin $41 |
Auvi-Q $35 |
AZSTARYS $22 |
SDG-IDD-Allergy $19 |
Other $108 |
| $558 | |
| $255 | |
| $107 | |
| $80 |
Dr. Stuart Schiff's area of specialization is general pediatrics. He is professionally affiliated with Optum East. His patients gave him an average rating of 5.0 stars (out of 5). Dr. Schiff appears to be in-network for Anthem, Blue California, Coventry, and more. Dr. Schiff's practice in Cedarhurst, NY is open to new patients as reported by Yext.
